首页 | 本学科首页   官方微博 | 高级检索  
     


Efficacy and safety of janagliflozin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin alone: A multicentre,randomized, double-blind,placebo-controlled,phase 3 trial
Authors:Leili Gao MD  Zhifeng Cheng MD  Benli Su MD  Xiuhai Su MB  Weihong Song MB  Yushan Guo MM  Lin Liao MD  Xiaowen Chen MM  Jiarui Li MM  Xingrong Tan MM  Fangjiang Xu MB  Shuguang Pang MD  Kun Wang MD  Jun Ye MB  Yuan Wang MD  Lili Chen MD  Jingfang Sun MM  Linong Ji MD
Affiliation:1. Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China;2. Department of Endocrinology, Fourth Affiliated Hospital of Harbin Medical University, Harbin, China;3. Department of Endocrinology, The Second Hospital of Dalian Medical University, Dalian, China;4. Department of Endocrinology, Cangzhou Hospital of Integrated TCM-WM Hebei, Cangzhou, China;5. Department of Endocrinology, Chenzhou First People's Hospital, Chenzhou, China;6. Department of Endocrinology, The Affiliated Hospital of Beihua University, Jilin, China;7. Department of Endocrinology, Shandong Provincial Qianfoshan Hospital, Jinan, China;8. Department of Endocrinology, Huangshi Central Hospital, Huangshi, China;9. Department of Endocrinology, Cangzhou Central Hospital, Cangzhou, China;10. Department of Endocrinology, The Ninth People's Hospital of Chongqing, Chongqing, China;11. Department of Endocrinology, Linyi Central Hospital, Linyi, China;12. Department of Endocrinology, Jinan Central Hospital Affiliated to Shandong University, Jinan, China;13. Department of Endocrinology, Nanjing Jiangning Hospital, Nanjing, China;14. Department of Endocrinology, The Second People's Hospital of Hefei, Hefei, China;15. Department of Endocrinology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China;16. Department of Endocrinology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China;17. Jilin Huisheng Bio-pharmaceutical Co., Ltd, Beijing, China
Abstract:
Keywords:add-on therapy  janagliflozin  metformin  renal sodium-glucose co-transporter-2 inhibitor  type 2 diabetes
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号